ePAD
09 Dec 2020
Trial Summary
Prostate Cancer Registry collecting treatment data on patients with Castrate-Resistant prostate cancer to investigate the outcomes of these treatments.
Acronym:
ePAD
ACTRN/NCT /ethics:
ACTRN12616000585426
Scientific title:
Analyzing Treatment Patterns and Outcomes from Real-World Patients with Castrate-Resistant Prostate Cancer (CRPC)
Sponsor / Cooperative group:
Melb Health
Trial & Patient Characteristics
| Cancer Type | Prostate |
|---|---|
| Trial Type | Early detection, diagnosis, prognosis |
| Phase | - |
| Age Range | 18 years and older |
| Sex | Male |
| Tumour Stream | - |
| Cancer Stage | Locally Recurrent or Locally Advanced |
| Anticipated Start Date | - |
| Anticipated End Date | 2021-06-30 |
Participating Hospitals
| Hospital | Ashford Cancer Centre Research |
|---|---|
| Clinical Trial Coordinator | Sue Yeend |
| syeend@adelaidecancercentre.com.au | |
| Phone | 08 8292 2240 |
| Principal Investigator | Dr Francis Parnis |
| Recruitment Status | Recruiting |